Opko Health (OPK) Cash & Equivalents (2010 - 2026)

Opko Health (OPK) has reported Cash & Equivalents for 17 consecutive years, with $341.9 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $341.9 million, down 21.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $341.9 million (down 21.59% YoY), and the FY2025 annual result was $369.1 million, down 14.55% from the prior year.
• Cash & Equivalents was $341.9 million for Q1 2026 at Opko Health, down from $369.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $436.0 million in Q1 2025 and troughed at $40.6 million in Q2 2024.
• Average Cash & Equivalents over 5 years is $228.7 million, with a median of $180.8 million recorded in 2022.
• Year-over-year, Cash & Equivalents tumbled 62.47% in 2024 and jumped 569.65% in 2025.
• Over 5 years, Cash & Equivalents stood at $153.2 million in 2022, then plunged by 37.41% to $95.9 million in 2023, then soared by 350.49% to $431.9 million in 2024, then retreated by 14.55% to $369.1 million in 2025, then retreated by 7.37% to $341.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $341.9 million in Q1 2026, $369.1 million in Q4 2025, and $415.2 million in Q3 2025.